We’re glad to see you’re enjoying ReachMD…but how about a more personalized experience?
Matt Birnholz, MD
Chloroquine as a Treatment Agent for COVID-19: Hype or Hope?
Andrew Wilner, MD, FACP, FAAN
Bits from “Bullets and Brains”: The (Disregarded) Value of Vaccines
Bits from "Bullets and Brains": Taking the Sting out of Scorpion Venom
The FAERS Public Dashboard and its Value to the Pharmaceutical Industry
Opioid Epidemic: The 21st Century's Greatest Public Health Crisis
FDA Warns of Serious Immune Reaction with Seizure/BPD Medicine Lamotrigine (Lamictal)
Maurice Pickard, MD
Carl Hart, MD
High Price: How A Neuroscientist's Journey of Self-Discovery is Challenging Society's Perception on Drugs
Brian P. McDonough, MD, FAAFP
Rethinking Pain Management in an Opioid Epidemic: Prevention and Treatment Updates
Beyond Opioids: Alternative Options for Pain Management
FDA’s Role in Foreign Drug Manufacturing
FDA D.I.S.C.O.: First Biosimilar Approval for the Treatment of Cancer
FDA Requires New Class Warnings for All Gadolinium-Based Contrast Agents
FDA Review: Adding LABAs to ICS Treatment Does Not Significantly Increase Serious Asthma Outcomes Risk
Anti-TNF Treatment for Extraintestinal Manifestations of Inflammatory Bowel Disease in the Swiss IBD Cohort Study
The FDA's Adverse Event Reporting System (FAERS) Public Dashboard
Press cancel to remain on ReachMD. Press the link below or the continue button to keep going.
Stay current with the best on medical education